펩타이드 합성 시장 규모, 점유율, 성장 및 세계 산업 분석 : 제공별, 방법별, 용도별, 최종사용자별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of peptide synthesis Market

The global peptide synthesis market was valued at USD 746.7 million in 2025 and is projected to grow to USD 800.16 million in 2026. The market is further expected to reach USD 1,640.52 million by 2034, registering a strong CAGR of 9.39% during the forecast period.

North America dominated the global peptide synthesis market with a 48.59% market share in 2025. Growth is driven by rising demand for peptide-based therapeutics, technological advancements in synthesis techniques, and expanding research & development investments.

Peptide synthesis involves the chemical or biological construction of short amino acid chains in a defined sequence. Modern techniques such as solid-phase peptide synthesis (SPPS) and liquid-phase peptide synthesis (LPPS) enable customized peptide production for therapeutic, diagnostic, and research applications.

Market Dynamics

Market Drivers

Rising Demand for Peptide-Based Drugs

One of the primary growth drivers is the increasing adoption of peptide-based drugs due to their high specificity, low toxicity, and improved safety profiles compared to small-molecule drugs. Peptides are widely used in oncology, metabolic disorders, diabetes, and rare diseases.

For instance, in August 2025, BioMed X collaborated with Novo Nordisk to develop oral formulations for peptide drugs such as GLP-1 receptor agonists. The growing pipeline of peptide therapeutics in clinical trials is significantly driving synthesis demand.

Market Restraints

Technical Limitations in Large-Scale Production

Despite strong growth, large-scale peptide synthesis faces challenges including incomplete coupling, aggregation, racemization, and high solvent consumption. Scaling SPPS from laboratory to commercial production often results in increased purification costs and reduced yields, limiting broader market expansion.

Market Opportunities

Technological Advancements in Synthesis Methods

Innovations such as microwave-assisted SPPS, hybrid SPPS-LPPS techniques, and continuous-flow synthesis are transforming peptide production efficiency. These advancements reduce solvent usage, shorten cycle times, and improve yield and purity.

For example, in April 2022, CEM Corporation launched the Liberty Blue 2.0 microwave peptide synthesizer, reducing solvent use by over 90% and enabling greener production processes.

Market Challenges

High Production and Purification Costs

Long and structurally complex peptides require multi-step synthesis and high-performance liquid chromatography (HPLC) purification, significantly increasing costs. For example, tirzepatide (Mounjaro), a 39-amino acid peptide drug, requires large-scale purification and complex production processes, contributing to higher manufacturing expenses.

Market Trends

Growing Outsourcing to CDMOs

A key trend in the market is the increasing outsourcing of peptide manufacturing to specialized Contract Development and Manufacturing Organizations (CDMOs). Pharmaceutical companies prefer outsourcing to reduce infrastructure investment and accelerate time-to-market.

In July 2024, Corden Pharma announced a €900 million (USD 1,047.2 million) investment to expand global peptide production capacity, highlighting growing outsourcing demand.

Segmentation Analysis

By Offering

The market is divided into products and services.

The services segment dominated the market with a 71.03% share in 2026, driven by increased outsourcing and rising demand for large-scale peptide manufacturing. In October 2025, Cambrex Corporation announced a USD 120 million investment to expand peptide manufacturing capacity in the U.S.

By Method

The market includes:

• Solid-Phase Peptide Synthesis (SPPS)
• Liquid-Phase Peptide Synthesis (LPPS)
• Others

The SPPS segment dominated with a 74.42% share in 2026, owing to automation compatibility, scalability, and high efficiency. The LPPS segment is expected to grow at a CAGR of 6.45% during the forecast period.

By Application

Applications include:

• Therapeutics
• Diagnostics
• Research & Development

The therapeutics segment held the largest share at 66.25% in 2026, driven by increasing commercialization of peptide drugs and a strong clinical pipeline. Diagnostics is projected to grow at 7.35% during the forecast period.

By End User

The market is segmented into:

• Pharmaceutical & Biotechnology Companies
• CROs & CDMOs
• Academic & Research Institutes
• Others

Pharmaceutical & biotechnology companies dominated with a 57.1% share in 2025 and 56.94% in 2026, supported by active therapeutic innovation and strategic collaborations. The CROs & CDMOs segment is projected to grow at a CAGR of 11.62%.

Regional Outlook

North America

North America led the market with a valuation of USD 362.84 million in 2025 and is projected to reach USD 389.08 million in 2026. The U.S. market alone is expected to reach USD 360.76 million by 2026, driven by strong biopharmaceutical R&D and strategic collaborations.

Europe

Europe is projected to grow at a CAGR of 8.72% and recorded USD 160.1 million in 2025. France recorded USD 24.1 million in 2025, while the UK and Germany are projected to reach USD 39.74 million and USD 35.84 million respectively by 2026.

Asia Pacific

Asia Pacific reached USD 140.4 million in 2025. By 2026, Japan is projected to reach USD 49.53 million, China USD 30.01 million, and India USD 29.26 million.

Latin America & Middle East & Africa

Latin America recorded USD 35.0 million in 2025, while GCC countries reached USD 18.4 million in 2025. Growth in these regions is supported by expanding R&D activities.

Competitive Landscape

The market is semi-consolidated with key players including:

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Agilent Technologies Inc.
• Bachem AG
• PolyPeptide Group
• Danaher

Strategic collaborations and technology upgrades strengthen competitive positioning. For instance, in May 2025, PeptiSystems partnered with Asahi Kasei Bioprocess America to enhance peptide synthesis technologies.

Conclusion

The global peptide synthesis market, valued at USD 746.7 million in 2025, is projected to grow to USD 800.16 million in 2026 and reach USD 1,640.52 million by 2034, expanding at a CAGR of 9.39%. Growth is primarily driven by rising demand for peptide-based therapeutics, technological advancements in SPPS and LPPS, and increasing outsourcing to CDMOs. Although high production costs and large-scale synthesis challenges remain, expanding R&D investments and innovative synthesis platforms are expected to sustain strong market growth through 2034.

Segmentation By Offering, Method, Application, End User, and Region

By Offering * Products

• Instruments
  • Peptide Synthesizers
  • Lyophilizers
  • Chromatography Systems
  • Others
• Reagents & Consumables
• Services
  • Custom Research-Grade Peptide Synthesis
  • Peptide Library Synthesis
  • Others

By Method * Liquid-Phase Peptide Synthesis

• Solid-Phase Peptide Synthesis
• Others

By Application * Therapeutics

• Diagnostics
• Research & Development

By End User * Pharmaceutical & Biotechnology Companies

• CROs & CDMOs
• Academic & Research Institutes
• Others

By Region * North America (By Offering, Method, Application, End User, and Country)

• U.S.
• Canada
• Europe (By Offering, Method, Application, End User, and Country/Sub-region)
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Offering, Method, Application, End User, and Country/Sub-region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Offering, Method, Application, End User, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Offering, Method, Application, End User, and Country/Sub-region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Technological Advancements in Peptide Synthesis
• 4.2. Regulatory Scenario, By Key Countries/Regions
• 4.3. Key Industry Developments (Mergers, Acquisitions, and Collaborations etc.)
• 4.4. New Product Launches, By Key Players

5. Global Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Offering
  • 5.1.1. Products
    • 5.1.1.1. Instruments
      • 5.1.1.1.1. Peptide Synthesizers
      • 5.1.1.1.2. Lyophilizers
      • 5.1.1.1.3. Chromatography Systems
      • 5.1.1.1.4. Others
    • 5.1.1.2. Reagents & Consumables
  • 5.1.2. Services
    • 5.1.2.1. Custom Research-Grade Peptide Synthesis
    • 5.1.2.2. Peptide Library Synthesis
    • 5.1.2.3. Others
• 5.2. Market Analysis, Insights and Forecast - By Method
  • 5.2.1. Liquid-Phase Peptide Synthesis
  • 5.2.2. Solid-Phase Peptide Synthesis
  • 5.2.3. Others
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Therapeutics
  • 5.3.2. Diagnostics
  • 5.3.3. Research & Development
• 5.4. Market Analysis, Insights and Forecast - By End User
  • 5.4.1. Pharmaceutical & Biotechnology Companies
  • 5.4.2. CROs & CDMOs
  • 5.4.3. Academic & Research Institutes
  • 5.4.4. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Offering
  • 6.1.1. Products
    • 6.1.1.1. Instruments
      • 6.1.1.1.1. Peptide Synthesizers
      • 6.1.1.1.2. Lyophilizers
      • 6.1.1.1.3. Chromatography Systems
      • 6.1.1.1.4. Others
    • 6.1.1.2. Reagents & Consumables
  • 6.1.2. Services
    • 6.1.2.1. Custom Research-Grade Peptide Synthesis
    • 6.1.2.2. Peptide Library Synthesis
    • 6.1.2.3. Others
• 6.2. Market Analysis, Insights and Forecast - By Method
  • 6.2.1. Liquid-Phase Peptide Synthesis
  • 6.2.2. Solid-Phase Peptide Synthesis
  • 6.2.3. Others
• 6.3. Market Analysis, Insights and Forecast - By Application
  • 6.3.1. Therapeutics
  • 6.3.2. Diagnostics
  • 6.3.3. Research & Development
• 6.4. Market Analysis, Insights and Forecast - By End User
  • 6.4.1. Pharmaceutical & Biotechnology Companies
  • 6.4.2. CROs & CDMOs
  • 6.4.3. Academic & Research Institutes
  • 6.4.4. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Offering
  • 7.1.1. Products
    • 7.1.1.1. Instruments
      • 7.1.1.1.1. Peptide Synthesizers
      • 7.1.1.1.2. Lyophilizers
      • 7.1.1.1.3. Chromatography Systems
      • 7.1.1.1.4. Others
    • 7.1.1.2. Reagents & Consumables
  • 7.1.2. Services
    • 7.1.2.1. Custom Research-Grade Peptide Synthesis
    • 7.1.2.2. Peptide Library Synthesis
    • 7.1.2.3. Others
• 7.2. Market Analysis, Insights and Forecast - By Method
  • 7.2.1. Liquid-Phase Peptide Synthesis
  • 7.2.2. Solid-Phase Peptide Synthesis
  • 7.2.3. Others
• 7.3. Market Analysis, Insights and Forecast - By Application
  • 7.3.1. Therapeutics
  • 7.3.2. Diagnostics
  • 7.3.3. Research & Development
• 7.4. Market Analysis, Insights and Forecast - By End User
  • 7.4.1. Pharmaceutical & Biotechnology Companies
  • 7.4.2. CROs & CDMOs
  • 7.4.3. Academic & Research Institutes
  • 7.4.4. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.5.1. U.K.
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Spain
  • 7.5.5. Italy
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Offering
  • 8.1.1. Products
    • 8.1.1.1. Instruments
      • 8.1.1.1.1. Peptide Synthesizers
      • 8.1.1.1.2. Lyophilizers
      • 8.1.1.1.3. Chromatography Systems
      • 8.1.1.1.4. Others
    • 8.1.1.2. Reagents & Consumables
  • 8.1.2. Services
    • 8.1.2.1. Custom Research-Grade Peptide Synthesis
    • 8.1.2.2. Peptide Library Synthesis
    • 8.1.2.3. Others
• 8.2. Market Analysis, Insights and Forecast - By Method
  • 8.2.1. Liquid-Phase Peptide Synthesis
  • 8.2.2. Solid-Phase Peptide Synthesis
  • 8.2.3. Others
• 8.3. Market Analysis, Insights and Forecast - By Application
  • 8.3.1. Therapeutics
  • 8.3.2. Diagnostics
  • 8.3.3. Research & Development
• 8.4. Market Analysis, Insights and Forecast - By End User
  • 8.4.1. Pharmaceutical & Biotechnology Companies
  • 8.4.2. CROs & CDMOs
  • 8.4.3. Academic & Research Institutes
  • 8.4.4. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.5.1. Japan
  • 8.5.2. China
  • 8.5.3. India
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Offering
  • 9.1.1. Products
    • 9.1.1.1. Instruments
      • 9.1.1.1.1. Peptide Synthesizers
      • 9.1.1.1.2. Lyophilizers
      • 9.1.1.1.3. Chromatography Systems
      • 9.1.1.1.4. Others
    • 9.1.1.2. Reagents & Consumables
  • 9.1.2. Services
    • 9.1.2.1. Custom Research-Grade Peptide Synthesis
    • 9.1.2.2. Peptide Library Synthesis
    • 9.1.2.3. Others
• 9.2. Market Analysis, Insights and Forecast - By Method
  • 9.2.1. Liquid-Phase Peptide Synthesis
  • 9.2.2. Solid-Phase Peptide Synthesis
  • 9.2.3. Others
• 9.3. Market Analysis, Insights and Forecast - By Application
  • 9.3.1. Therapeutics
  • 9.3.2. Diagnostics
  • 9.3.3. Research & Development
• 9.4. Market Analysis, Insights and Forecast - By End User
  • 9.4.1. Pharmaceutical & Biotechnology Companies
  • 9.4.2. CROs & CDMOs
  • 9.4.3. Academic & Research Institutes
  • 9.4.4. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Offering
  • 10.1.1. Products
    • 10.1.1.1. Instruments
      • 10.1.1.1.1. Peptide Synthesizers
      • 10.1.1.1.2. Lyophilizers
      • 10.1.1.1.3. Chromatography Systems
      • 10.1.1.1.4. Others
    • 10.1.1.2. Reagents & Consumables
  • 10.1.2. Services
    • 10.1.2.1. Custom Research-Grade Peptide Synthesis
    • 10.1.2.2. Peptide Library Synthesis
    • 10.1.2.3. Others
• 10.2. Market Analysis, Insights and Forecast - By Method
  • 10.2.1. Liquid-Phase Peptide Synthesis
  • 10.2.2. Solid-Phase Peptide Synthesis
  • 10.2.3. Others
• 10.3. Market Analysis, Insights and Forecast - By Application
  • 10.3.1. Therapeutics
  • 10.3.2. Diagnostics
  • 10.3.3. Research & Development
• 10.4. Market Analysis, Insights and Forecast - By End User
  • 10.4.1. Pharmaceutical & Biotechnology Companies
  • 10.4.2. CROs & CDMOs
  • 10.4.3. Academic & Research Institutes
  • 10.4.4. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.5.1. GCC
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  • 11.2.1. Thermo Fisher Scientific Inc.
  • 11.2.2. Merck KGaA
  • 11.2.3. GenScript
  • 11.2.4. Agilent Technologies Inc.
  • 11.2.5. Bachem AG
  • 11.2.6. Waters Corporation
  • 11.2.7. Danaher
  • 11.2.8. PolyPeptide Group
  • 11.2.9. Bio-Synthesis Inc.
  • 11.2.10. CordenPharma